✕
Menu
PROVIDERS
Overview
The Oncoguard
®
Liver test
Clinical Performance
Scientific Rigor
Adding to the Workflow
Orders & Results
Insurance & Billing
Patient engagement program
About Us
Faqs
Patients
Liver Disease
Risk Factors
Detection & Monitoring
The Oncoguard
®
Liver Solution
The Oncoguard
®
Liver Test
Support
About Us
FAQs
EDUCATION
Resources
Ordering Information
Order Supplies
Forms
Specimen Collection
Implementation Guide
EpicCare
®
Link
™
Advocacy
Contact US
Posts in:
Featured
Featured
From inception to practice— new insights from the development of a high-performance liquid biopsy test for the detection of early-stage HCC
Featured
HCC surveillance: common goals, collective impact
Featured
Evaluating an ALTernative to UltraSound: the ALTUS study for the surveillance of HCC
Featured
The COVID-19 pandemic reveals an opportunity to optimize the surveillance of HCC
Featured
Hepatocellular carcinoma in the United States—HCV infection remains a threat, even as NAFLD increases
Featured
Improved Surveillance Is Urgently Needed to Help Reduce the Burden of Hepatocellular Carcinoma
Featured
A simple blood test may detect HCC in its early stages, potentially improving patient outcomes
Featured
Hepatocellular carcinoma is 10 times more likely to develop in the setting of nonalcoholic steatohepatitis than in simple fatty liver disease
Featured
Chronic liver disease is often a precursor to hepatocellular carcinoma
Featured
Early-stage hepatocellular carcinoma can be challenging to detect—it doesn’t have to be
Featured
We can improve hepatocellular carcinoma surveillance by understanding how risk factors are changing
Featured
Hepatocellular carcinoma has a high mortality rate—Improved surveillance may help reduce it
Sign up to be notified when a new blog is posted